Skip to content


BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers

  • Makito Miyake1,
  • Adrienne Lawton2,
  • Steve Goodison3,
  • Virginia Urquidi3,
  • Evan Gomes-Giacoia1,
  • Ge Zhang1,
  • Shanti Ross1,
  • Jeongsoon Kim1 and
  • Charles J Rosser1, 3Email author
BMC Cancer201313:322

Received: 26 April 2013

Accepted: 12 June 2013

Published: 1 July 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
26 Apr 2013 Submitted Original manuscript
23 May 2013 Reviewed Reviewer Report - Ellen Zwarthoff
2 Jun 2013 Reviewed Reviewer Report - Satoshi Anai
10 Jun 2013 Author responded Author comments - Charles Rosser
Resubmission - Version 2
10 Jun 2013 Submitted Manuscript version 2
12 Jun 2013 Editorially accepted
1 Jul 2013 Article published 10.1186/1471-2407-13-322

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

Cancer Research Institute, Orlando Health, Orlando, USA
Department of Pathology, Orlando Health, Orlando, USA
Nonagen Bioscience Corporation, Orlando, USA